VivoSeq
Other

Postoperative Pain, Acute

3

Pipeline Programs

2

Active Trials

3

Companies Involved

Postoperative Pain, Acute is an early-stage landscape with 3 programs across 3 companies. The most active players are AFT Pharmaceuticals, Ltd., Kenvue Brands, Eli Lilly. 1 therapy is approved with 2 more in late-stage development.

Pipeline Metrics

Competitive Density

24/100

Pipeline Velocity

11/100

Mech. Concentration

50/100

Completion Rate

100/100

Attrition Rate

0/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Programs by Phase

Preclinical
No programs
Phase 1
No programs
Phase 2
No programs

Trial Status

3

clinical trials

Recruiting1 · 33%
Not yet recruiting1 · 33%
Completed1 · 33%

Trial Activity

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)